SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,059.77 -331.62
( -0.43%)

Global Indices

Nasdaq

51,969.87 237.22
(0.46%)

Dow Jones

7,434.30 5.00
(0.07%)

Hang Seng

64,397.99 -2,024.61
(-3.05%)

Nikkei 225

10,738.51 99.34
(0.93%)

Forex

USD-INR

96.67 0.19
(0.20%)

EUR-INR

110.18 0.12
(0.10%)

GBP-INR

129.04 -0.01
(0.00%)

JPY-INR

0.59 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Infinium Pharmachem Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78690

INE0MRE01011

74.2682595

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

INFINIUM

32.5

325.69

EPS(TTM)

Face Value()

Div & Yield %

6.43

Back

Mphasis consolidated net profit rises 10.82% in the June 2026 quarter

Jul 24,2026

Net profit of Mphasis rose 10.82% to Rs 489.51 crore in the quarter ended June 2026 as against Rs 441.70 crore during the previous quarter ended June 2025. Sales rose 17.46% to Rs 4384.05 crore in the quarter ended June 2026 as against Rs 3732.49 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	4384.05	3732.49	17
OPM %	18.14	18.83	-
PBDT	829.84	741.99	12
PBT	682.79	610.07	12
NP	489.51	441.70	11

76,059.77 -331.62 ( -0.43%)

51,969.87 237.22 (0.46%)

7,434.30 5.00 (0.07%)

64,397.99 -2,024.61 (-3.05%)

10,738.51 99.34 (0.93%)

96.67 0.19 (0.20%)

110.18 0.12 (0.10%)

129.04 -0.01 (0.00%)

0.59 0.00 (-0.04%)